Market Overview:
The global medical ultrasonic nebulizers market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of respiratory diseases, growing demand for portable nebulizers, and technological advancements in ultrasonic nebulizers. Based on type, the global medical ultrasonic nebulizers market is segmented into desktop and portable nebulizers. Desktop nebulizers are further sub-segmented into hospital-based and home-based desktop models. Portable nebulizers are further sub-segmented into battery powered and AC/DC powered portable models. The hospital-based desktop model segment is expected to dominate the global medical ultrasonic nebuzers market during the forecast period owing to rising demand for homecare settings among patients suffering from respiratory diseases such as COPD, cystic fibrosis, asthma, and others. Based on application, the global medical ultrasound nebuzers market is segmented into COPD (chronic obstructive pulmonary disease), cystic fibrosis (CF), asthma bronchitis syndrome (ABS), other respiratory applications including pneumonia & tuberculosis (P&T) treatment; cancer therapy; pain management; wound debridement etc.
Product Definition:
Medical ultrasonic nebulizers are devices that convert liquid medication into a mist or aerosol that can be inhaled by the patient. This type of nebulizer is considered more effective than other types because it breaks up the medication into very small particles, which allows it to be delivered deep into the lungs. Ultrasonic nebulizers are often used to treat respiratory conditions such as asthma, bronchitis, and emphysema.
Desktop:
Desktop is a portable computer that can be used in the lap of patient while he/she is undergoing treatment. It helps to record and store data, analyze the recorded data and also helps to display results on screen. The ultrasonic nebulizers market has been growing rapidly due to its increasing application in home healthcare, clinics, hospitals & ambulatory care centers.
Portable:
Portable medical ultrasonic nebulizers is a device used for creating Ultrasonic waves which are then directed into the respiratory tract to facilitate and improve breathing. The ultrasonic nebulizer comes in different forms such as home care, hand-held, bedside/patient use and full-sized units. They are available with different power sources such as batteries & wall adaptors.
Application Insights:
Based on application, the global medical ultrasonic nebulizers market is segmented into chronic Obstructive Pulmonary Disease (COPD), cystic fibrosis, asthma and others. COPD held the largest share in 2017 owing to high prevalence of COPD and other lung diseases such as bronchitis and emphysema. According to estimates by Global Burden of Disease Study, an international research collaboration between The Institute for Health Metrics and Evaluation (IHME) at the University of Washington School of Medicine & Public Health, Chronic Obstructive Pulmonary Disease (COPD) caused over 75 million deaths globally in 2016.
The disease burden due to asthma is also significant; around 50 million people are affected by this condition worldwide according with WHO data. High prevalence coupled with increasing awareness about effective treatment through nebulization therapy is anticipated fuel demand for these devices during forecast period. Other applications include sinusitis, laryngitis/voice box problems etc.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position during the forecast period due to increasing government initiatives and rising awareness about respiratory diseases. For instance, in 2014, Global Initiative for Improved Diagnosis (GIIID) was launched by WHO and International Society of Aesthetic Plastic Surgery with an aim to improve diagnosis and support quality improvement activities related to aesthetic issues associated with respiratory system.
Asia Pacific is anticipated to witness lucrative growth over the forecast period owing to increasing prevalence of asthma among children and adults as well as growing awareness about available treatment options for asthma patients. In addition, rapidly developing economy coupled with improving healthcare infrastructure in emerging countries such as China & India are some factors that can be attributed for rapid growth of this regional market during the forecast period from 2018 To 2030 (USD Million).
Moreover, presence of key players such as Panasonic Corporation; Sanyo Electric Co., Ltd.
Growth Factors:
- Increasing prevalence of respiratory diseases: The global prevalence of respiratory diseases is increasing every year. This is mainly due to the changing lifestyle and environmental conditions. Medical ultrasonic nebulizers are effective in the treatment of various respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD), cystic fibrosis, and pneumonia. Thus, the demand for medical ultrasonic nebulizers is expected to increase in the coming years.
- Technological advancements: The technology used in medical ultrasonic nebulizers is constantly evolving with new features being added regularly. This has resulted in increased efficiency and reduced treatment time for patients using these devices. Moreover, newer models are also portable and easy to use, which has further increased their popularity among consumers worldwide.
Scope Of The Report
Report Attributes
Report Details
Report Title
Medical Ultrasonic Nebulizers Market Research Report
By Type
Desktop, Portable
By Application
COPD, Cystic Fibrosis, Asthma, Other
By Companies
PARI GmbH, Omron, Drive DeVilbiss Healthcare, Philips Respironics, Yuwell, Leyi, Folee, Medel S.p.A, Briggs Healthcare, A Health Care, Trudell Medical International, GF Health Products
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
132
Number of Tables & Figures
93
Customization Available
Yes, the report can be customized as per your need.
Global Medical Ultrasonic Nebulizers Market Report Segments:
The global Medical Ultrasonic Nebulizers market is segmented on the basis of:
Types
Desktop, Portable
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
COPD, Cystic Fibrosis, Asthma, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- PARI GmbH
- Omron
- Drive DeVilbiss Healthcare
- Philips Respironics
- Yuwell
- Leyi
- Folee
- Medel S.p.A
- Briggs Healthcare
- A Health Care
- Trudell Medical International
- GF Health Products
Highlights of The Medical Ultrasonic Nebulizers Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Desktop
- Portable
- By Application:
- COPD
- Cystic Fibrosis
- Asthma
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Medical Ultrasonic Nebulizers Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Medical ultrasonic nebulizers are devices that use ultrasound to create a mist of medication. This mist is then inhaled through the mouth or nose. Medical ultrasonic nebulizers are used to treat conditions such as asthma, COPD, and cystic fibrosis.
Some of the major companies in the medical ultrasonic nebulizers market are PARI GmbH, Omron, Drive DeVilbiss Healthcare, Philips Respironics, Yuwell, Leyi, Folee, Medel S.p.A, Briggs Healthcare, A Health Care, Trudell Medical International, GF Health Products.
The medical ultrasonic nebulizers market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Medical Ultrasonic Nebulizers Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Medical Ultrasonic Nebulizers Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Medical Ultrasonic Nebulizers Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Medical Ultrasonic Nebulizers Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Medical Ultrasonic Nebulizers Market Size & Forecast, 2020-2028
4.5.1 Medical Ultrasonic Nebulizers Market Size and Y-o-Y Growth
4.5.2 Medical Ultrasonic Nebulizers Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Desktop
5.2.2 Portable
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 COPD
6.2.2 Cystic Fibrosis
6.2.3 Asthma
6.2.4 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Medical Ultrasonic Nebulizers Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Medical Ultrasonic Nebulizers Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Desktop
9.6.2 Portable
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 COPD
9.10.2 Cystic Fibrosis
9.10.3 Asthma
9.10.4 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Desktop
10.6.2 Portable
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 COPD
10.10.2 Cystic Fibrosis
10.10.3 Asthma
10.10.4 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Desktop
11.6.2 Portable
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 COPD
11.10.2 Cystic Fibrosis
11.10.3 Asthma
11.10.4 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Desktop
12.6.2 Portable
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 COPD
12.10.2 Cystic Fibrosis
12.10.3 Asthma
12.10.4 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Desktop
13.6.2 Portable
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 COPD
13.10.2 Cystic Fibrosis
13.10.3 Asthma
13.10.4 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Medical Ultrasonic Nebulizers Market: Competitive Dashboard
14.2 Global Medical Ultrasonic Nebulizers Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 PARI GmbH
14.3.2 Omron
14.3.3 Drive DeVilbiss Healthcare
14.3.4 Philips Respironics
14.3.5 Yuwell
14.3.6 Leyi
14.3.7 Folee
14.3.8 Medel S.p.A
14.3.9 Briggs Healthcare
14.3.10 A Health Care
14.3.11 Trudell Medical International
14.3.12 GF Health Products
